Rambus
RMBS Nasdaq Semiconductors Financials FY2016βFY2025
Rambus' revenue rose 27.1% to $708 million in fiscal 2025. Its operating margin was 36.8%, up from 32.9% a year earlier. Free cash flow was $333 million, up 66.7%. It paid out $7 million in dividends and buybacks, 2% of free cash flow. The diluted share count rose 0.2%.
About these figures. Rambus' filings from 2022 tag a figure of about US$10 million as its depreciation and amortization total, against US$35 million of depreciation alone in 2025, so depreciation and amortization, EBITDA and the ratios built on it are left blank.
What Rambus does
No business description yet.
- Legal name
- RAMBUS INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001193125-26-057101
0000917273
Revenue and margins
Rambus had $708M of revenue in fiscal 2025, up 27.1% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 48.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $333M in fiscal 2025, 47.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Rambus returned $7.1M to shareholders in fiscal 2025, 2% of free cash flow. The diluted share count rose 0.2%.
Value Rambus yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $762M and divides by 109.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 40.8x Β· peers β Β· sector 33.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Rambus can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $486M | $313M | $426M | $482M | $762M |
| Debt incl. finance leases | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 2.3x | 41.1x | 103.1x | 129.2x | 189.5x |
| Current ratio | 2.6x | 4.2x | 7.1x | 8.4x | 8.2x |
| Quick ratio | 2.5x | 4.0x | 6.7x | 7.9x | 7.8x |
| Total assets | $1.2B | $1.0B | $1.3B | $1.3B | $1.5B |
| Total liabilities | $370M | $233M | $220M | $222M | $165M |
| Shareholders' equity | $862M | $779M | $1.0B | $1.1B | $1.4B |
| Net debt (β = net cash) | β$486M | β$313M | β$426M | β$482M | β$762M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$13.8M
8 insiders
Of sales under plans
18%
$2.5M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | Charles KissnerDirector | Sold plan | 5,000 | $105.00 | $0.5M | Form 4 |
| Aug 7, 2026 | Charles KissnerDirector | Sold plan | 5,000 | $100.92 | $0.5M | Form 4 |
| Jun 3, 2026 | Necip SayinerDirector | Sold | 5,000 | $170.15 | $0.9M | Form 4 |
| Jun 2, 2026 | Emiko HigashiDirector | Sold | 10,000 | $160.50 | $1.6M | Form 4 |
| Jun 1, 2026 | Eric B StangDirector | Sold | 5,000 | $146.00 | $0.7M | Form 4 |
| May 26, 2026 | Emiko HigashiDirector | Sold | 5,000 | $157.57 | $0.8M | Form 4 |
| May 26, 2026 | Xianzhi Sean FanEVP, COO | Sold | 37,914 | $151.69 | $5.8M | Form 4 |
| May 22, 2026 | John ShinnSVP, General Counsel | Sold | 1,000 | $143.63 | $0.1M | Form 4 |
| May 8, 2026 | Necip SayinerDirector | Sold | 9,824 | $130.18 | $1.3M | Form 4 |
| May 7, 2026 | Steven LaubDirector | Sold | 1,500 | $125.52 | $0.2M | Form 4 |
| Apr 24, 2026 | Meera RaoDirector | Sold plan | 2,972 | $150.30 | $0.4M | Form 4 |
| Apr 14, 2026 | Meera RaoDirector | Sold plan | 8,538 | $118.08 | $1.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 6 / 9 | 5 / 9 |
| Accruals ratio | 12.2% | β3.9% | β9.0% |
| Altman Z'' | 7.86 | 8.80 | 13.71 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Rambus RMBS | $9.4B | 27.1% | 36.8% | 47.1% | 34.3% | 40.8x | 5 | |
| Universal Display OLED | $4.1B | 0.5% | 38.2% | 23.7% | 17.9% | 21.0x | 3 | Compare β |
| Silicon Labs SLAB | $7.3B | 34.3% | β9.0% | 8.4% | β7.0% | β | 5 | Compare β |
| Allegro MicroSystems ALGM | $5.9B | 22.8% | 2.1% | 14.0% | 1.3% | β | 7 | Compare β |
| Lattice Semiconductor LSCC | $13.5B | 2.7% | 2.2% | 25.3% | 1.0% | β | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $337M | $393M | $231M | $228M | $246M | $328M | $455M | $461M | $557M | $708M |
| Gross profit | $291M | $338M | $178M | $176M | $186M | $258M | $347M | $358M | $447M | $563M |
| Research and development | $130M | $149M | $158M | $157M | $140M | $136M | $159M | $157M | $163M | $188M |
| Operating income | $33.6M | $54.4M | β$87.0M | β$100M | β$44.1M | $24.3M | $76.9M | $154M | $183M | $260M |
| Interest expense | $12.7M | $13.7M | $16.3M | $9.9M | $10.3M | $10.7M | $1.9M | $1.5M | $1.4M | $1.4M |
| Pretax income | $22.6M | $41.0M | β$70.6M | β$82.5M | β$36.5M | $23.3M | β$7.8M | $187M | $200M | $282M |
| Income tax | $15.8M | $63.9M | $87.3M | $3.4M | $3.9M | $5.0M | $6.5M | β$147M | $20.2M | $51.5M |
| Net income | $6.8M | β$22.9M | β$158M | β$86.0M | β$40.5M | $18.3M | β$14.3M | $334M | $180M | $231M |
| Diluted EPS | $0.06 | β$0.21 | β$1.46 | β$0.77 | β$0.36 | $0.16 | β$0.13 | $3.01 | $1.65 | $2.11 |
| Diluted shares | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B |
| Cash flow | ||||||||||
| Cash from operations | $95.6M | $117M | $86.2M | $129M | $186M | $209M | $230M | $196M | $231M | $360M |
| Capital expenditure | $8.6M | $9.4M | $10.8M | $6.5M | $29.7M | $13.8M | $17.5M | $23.2M | $30.7M | $26.8M |
| Free cash flow | $87.1M | $108M | $75.5M | $122M | $156M | $195M | $213M | $173M | $200M | $333M |
| Stock-based compensation | $21.0M | $27.4M | $21.7M | $26.5M | $25.8M | $27.5M | $35.6M | $45.0M | $44.9M | $54.3M |
| Acquisitions | $203M | $0.0M | $0.0M | $66.8M | $0.0M | $97.1M | $15.9M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $50.0M | $50.0M | $0.0M | $50.1M | $100M | $100M | $101M | $113M | $7.1M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $50.0M | $50.0M | $0.0M | $50.1M | $100M | $100M | $101M | $113M | $7.1M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $135M | $226M | $116M | $102M | $503M | $486M | $313M | $426M | $482M | $762M |
| Total debt | $126M | $135M | $142M | $149M | $156M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $217M | $372M | $528M | $665M | $700M | $684M | $527M | $631M | $690M | $989M |
| Current liabilities | $51.3M | $133M | $69.3M | $86.2M | $85.9M | $267M | $127M | $89.1M | $81.8M | $121M |
| Inventory | $5.6M | $5.2M | $6.8M | $10.1M | $14.5M | $8.5M | $20.9M | $36.2M | $44.6M | $44.1M |
| Property and equipment, net | $58.4M | $54.3M | $57.0M | $45.5M | $57.7M | $56.0M | $86.3M | $67.8M | $75.5M | $113M |
| Total assets | $784M | $891M | $1.4B | $1.3B | $1.3B | $1.2B | $1.0B | $1.3B | $1.3B | $1.5B |
| Total liabilities | $231M | $320M | $349M | $368M | $339M | $370M | $233M | $220M | $222M | $165M |
| Shareholders' equity | $553M | $572M | $1.0B | $975M | $913M | $862M | $779M | $1.0B | $1.1B | $1.4B |
| Margins | ||||||||||
| Gross margin | 86.4% | 85.9% | 76.8% | 77.4% | 75.3% | 78.6% | 76.4% | 77.6% | 80.2% | 79.6% |
| Operating margin | 10.0% | 13.8% | β37.6% | β44.0% | β17.9% | 7.4% | 16.9% | 33.3% | 32.9% | 36.8% |
| Net margin | 2.0% | β5.8% | β68.3% | β37.8% | β16.4% | 5.6% | β3.2% | 72.4% | 32.3% | 32.6% |
| FCF margin | 25.9% | 27.5% | 32.6% | 53.6% | 63.2% | 59.5% | 46.8% | 37.4% | 35.9% | 47.1% |
| Returns | ||||||||||
| Return on capital | 3.2% | 5.3% | β9.0% | β7.7% | β4.4% | 4.1% | 14.4% | 28.5% | 26.3% | 34.3% |
| Return on capital employed | 4.7% | 7.3% | β8.5% | β7.9% | β3.6% | 2.3% | 8.3% | 15.0% | 15.1% | 19.5% |
| Return on equity | 1.3% | β4.1% | β20.0% | β8.7% | β4.3% | 2.1% | β1.7% | 36.8% | 16.7% | 18.6% |
| Return on assets | 0.9% | β2.7% | β14.0% | β6.4% | β3.1% | 1.5% | β1.3% | 29.4% | 13.8% | 16.0% |
| Growth | ||||||||||
| Revenue growth | 13.6% | 16.8% | β41.2% | β1.6% | 8.2% | 33.3% | 38.5% | 1.4% | 20.7% | 27.1% |
| Net income growth | β96.8% | β435.2% | β | β | β | β | β178.1% | β | β46.2% | 28.2% |
| EPS growth | β96.7% | β450.0% | β | β | β | β | β181.3% | β | β45.2% | 27.9% |
| FCF growth | 22.4% | 24.1% | β30.2% | 61.8% | 27.6% | 25.5% | 9.0% | β19.0% | 15.9% | 66.7% |
| Share count change | β3.7% | β2.6% | β1.6% | 2.3% | 2.1% | 1.4% | β4.7% | 1.3% | β1.7% | 0.2% |
| Financial health | ||||||||||
| Debt / equity | 0.2x | 0.2x | 0.1x | 0.2x | 0.2x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 2.6x | 4.0x | β5.3x | β10.2x | β4.3x | 2.3x | 41.1x | 103.1x | 129.2x | 189.5x |
| Current ratio | 4.2x | 2.8x | 7.6x | 7.7x | 8.2x | 2.6x | 4.2x | 7.1x | 8.4x | 8.2x |
| Quick ratio | 4.1x | 2.8x | 7.5x | 7.6x | 8.0x | 2.5x | 4.0x | 6.7x | 7.9x | 7.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.5% | 2.4% | 4.7% | 2.8% | 12.1% | 4.2% | 3.8% | 5.0% | 5.5% | 3.8% |
| Stock comp / revenue | 6.2% | 7.0% | 9.4% | 11.6% | 10.5% | 8.4% | 7.8% | 9.8% | 8.1% | 7.7% |
| Payouts / FCF | 0.0% | 46.3% | 66.3% | 0.0% | 32.2% | 51.2% | 47.2% | 58.3% | 56.7% | 2.1% |
| Quality scores | ||||||||||
| Piotroski F-score | 5.0 | 5.0 | 5.0 | 6.0 | 5.0 | 7.0 | 5.0 | 6.0 | 6.0 | 5.0 |
| Altman Z'' | 1.6 | 1.7 | 4.3 | 4.4 | 4.9 | 3.7 | 5.0 | 7.9 | 8.8 | 13.7 |
| Accruals ratio | β11.8% | β16.8% | β21.7% | β15.9% | β17.4% | β15.4% | β21.8% | 12.2% | β3.9% | β9.0% |
Source: SEC EDGAR XBRL filings (CIK 0000917273). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.